Announcements

We are pleased to announce that Dr. Shuxing Zhang from the University of Texas MD Anderson Cancer Center (Houston, TX, USA) has joined the Editorial Board of the journal Non-Coding RNA (ISSN 2311-553X). Dr. Zhang is an internationally recognized leader in computational modeling and drug discovery, and we firmly believe that his expertise will be a worthwhile addition to our esteemed group of experts.

Dr. Shuxing Zhang graduated from Peking University (Beijing, China) and completed his Ph.D. at the University of North Carolina (Chapel Hill, NC, USA) in the School of Pharmacy.

Currently, Dr. Zhang is leading the Intelligent Molecular Discovery Laboratory at the University of Texas MD Anderson Cancer Center. His research focuses on the development of novel computational strategies and frameworks for protein and RNA modeling, with a strong interest in targeted and personalized cancer therapy. Using his unique platform, Dr. Zhang has developed numerous therapeutic agents currently at the different stages of preclinical, Phase I, and Phase II clinical trials. His investigations involve a variety of targets, such as EGFR, Skp2, Akt, microRNAs, and lncRNAs. To date, Dr. Zhang has implemented various novel methods based on artificial intelligence, cheminformatics, molecular docking, and scoring functions (just to name a few) for drug discovery and development.

Dr. Zhang believes that RNA modeling, in particular accurate ncRNA structure prediction, is an area with significant challenges that needs a great deal of collective effort from the community. Such studies could have a tremendous impact on non-coding RNA biology and their implication in human health, and thus publications in this area should be encouraged to advance the field.